% | $
Quotes you view appear here for quick access.

Facebook, Inc. (FB) Message Board

jhankster60 1 post  |  Last Activity: Jun 10, 2016 9:10 AM Member since: Feb 5, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Aldoxorubicin Investment and Pussing Out

    by parisite76 Jun 9, 2016 7:41 PM
    jhankster60 jhankster60 Jun 10, 2016 9:10 AM Flag

    Excellent post and a reminder to all that Biotech investing takes a huge amount of personal due-dillegence, a tremendous amount of patience, and a cast-iron stomach. If investors are truly longs, they realize all this and should feel comfortable with their investment. The 40M secured loan CYTR took out for commercial preparation a bit back further convinced me the confidence level is high for they could have simply diluted further.

    PPS activity of late is the norm for a biotech company on the cusp of greatness. True longs aren't selling while shorts try taking it down further.Those investors not fully all-in here are getting their stop-losses taken out as the shorts walk this down as we near PH3 results.

    I personally have a significant investment here, using profits from a previous Biotech company that's been in Cytr shoes before. Complete with the AF bashing, flash trades, fictitious firms writing negative articles - the whole package prior to its' success. One thing I learned from that experience, is to keep some cash on hand to take advantage of this late-game walk down in the PPS. I truly believe longs will be rewarded.

    Sentiment: Strong Buy

124.96+1.07(+0.86%)Aug 26 4:00 PMEDT